BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3837381)

  • 1. [Comparative bioavailability of prednisone and prednisone acetate tablets].
    Jia YR; Zhou BY; Zhou WB; Lei YD; Zhou Q
    Sichuan Yi Xue Yuan Xue Bao; 1985 Sep; 16(3):259-61. PubMed ID: 3837381
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative bioavailability: eight commercial prednisone tablets.
    Sullivan TJ; Hallmark MR; Sakmar E; Weidler DJ; Earhart RH; Wagner JG
    J Pharmacokinet Biopharm; 1976 Apr; 4(2):157-72. PubMed ID: 950588
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro and in vivo availability of commercial prednisone tablets.
    Sullivan TJ; Sakmar E; Albert KS; Blair DC; Wagner JG
    J Pharm Sci; 1975 Oct; 64(10):1723-5. PubMed ID: 1102660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of food on the bioavailability of prednisone.
    Tembo AV; Sakmar E; Hallmark MR; Weidler DJ; Wagner JG
    J Clin Pharmacol; 1976; 16(11-12):620-4. PubMed ID: 791973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Systemic availability of prednisolone following oral administration of prednisone].
    Frey BM; Brandenberger AW; Frey FJ; Widmer HR
    Pharm Acta Helv; 1984; 59(11):301-9. PubMed ID: 6514760
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability and pharmacokinetics of prednisone in humans.
    Disanto AR; Desante KA
    J Pharm Sci; 1975 Jan; 64(1):109-12. PubMed ID: 1133681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peristaltic dissolution apparatus: prediction of relative in vivo performance of prednisone tablets in humans.
    Simmons DL; Legore AA; Picotte P
    J Pharm Sci; 1980 Feb; 69(2):220-2. PubMed ID: 7359333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative bioavailability of Verospiron and Aldactone tablets in humans.
    János C; László V; Sándor KF; Zsolt S; Gabor R
    Acta Pharm Hung; 1982 Nov; 52(6):274-79. PubMed ID: 7158363
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative bioavailability: a new type of in vitro--in vivo correlation exemplified by prednisone.
    Sullivan TJ; Sakmar E; Wagner JG
    J Pharmacokinet Biopharm; 1976 Apr; 4(2):173-81. PubMed ID: 950589
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers.
    Uribe M; Casian C; Rojas S; Sierra JG; Go VL
    Gastroenterology; 1981 Apr; 80(4):661-5. PubMed ID: 7202937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative bioavailability of two carbamazepine tablets.
    Glende M; Hüller H; Mai I; Migulla H; Prümke J; Schumann G
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):631-3. PubMed ID: 6668101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability of two uncoated aminophylline tablets.
    Kwok F; Kradjan WA; Lakshminarayan S; Delaney C
    Am J Hosp Pharm; 1980 Dec; 37(12):1618, 1620. PubMed ID: 7446536
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative studies on the bioavailability of 2 amoxicillin preparations].
    Gikalov I; Daschner F
    Arzneimittelforschung; 1983; 33(5):784-6. PubMed ID: 6683559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bioavailability of an orally administered medroxyprogesterone acetate suspension.
    Antal EJ; Gillespie WR; Albert KS
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):257-9. PubMed ID: 6222996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study, on healthy volunteers, of the bioavailability of 2 pharmaceutical formulations of oral cofosfolactamines. Trials between subjects].
    Di Nola F; Soranzo ML
    Minerva Med; 1983 Feb; 74(6):239-48. PubMed ID: 6828256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative bioavailability of iron from two different iron tablets used in the Indonesian Iron Supplementation Program.
    Thorand B; Pietzik K; Dillon D; Schultink W; Gross R
    Southeast Asian J Trop Med Public Health; 1993 Dec; 24(4):624-30. PubMed ID: 7939931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of formulation on dissolution and bioavailability of phenytoin tablets.
    Chakrabarti S; Belpaire F; Moerman E
    Pharmazie; 1980; 35(10):627-9. PubMed ID: 7454745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the bioavailability of Redergin tablets (1.0 mg) and Redergin solution.
    Kopitar Z; Milovac J; Vrhovac B; Tadjer I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):134-8. PubMed ID: 7068286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of a metformin/glyburide tablet administered alone and with food.
    Marathe PH; Arnold ME; Meeker J; Greene DS; Barbhaiya RH
    J Clin Pharmacol; 2000 Dec; 40(12 Pt 2):1494-502. PubMed ID: 11185672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a dissolution medium for nimodipine tablets based on bioavailability evaluation.
    He Z; Zhong D; Chen X; Liu X; Tang X; Zhao L
    Eur J Pharm Sci; 2004 Mar; 21(4):487-91. PubMed ID: 14998579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.